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ABSTRACT
Perillyl alcohol and perillic acid enhanced the sensitivity of head and neck cancer
cells to radiation treatment in vitro
by
Daniel Samaila
Dr. J. Abiodun Elegbede, Examination Committee Chair/Adviser 
Assistant Professor o f Biochemistry 
University o f Nevada, Las Vegas
Limonene and perillyl alcohol are the naturally occurring monoterpenes found 
commonly in plant fruits and vegetables. Perillyl alcohol (POH) elicited anticarcinogenic 
effects in a number o f caneer models and pharmacokinetie studies in humans revealed 
that perillie acid (PA) is the major eireulating metabolite following POH administration. 
Effects o f these monoterpenes eombined with and without radiation on human head and 
neck squamous cell carcinoma cell lines (HNSCC) were measured using eytotoxicity and 
flow eytometry assays. HNSCC cells were pretreated with 1.0 mM PA or 0.5mM POH 
for 72 hr before exposure to IGy or 2Gy radiation dose. Pretreatment with l.OmM PA or 
0.5mM POH sensitized the eells to radiation, causing growth inhibition in HTB-43 (50% 
and 71%), SCC-25 (55% and 68%) and BroTo (18% and 53%) cells, respectively. PA 
induced cell-cycle arrest in Gq/G i phase, caused cell death via apoptosis and a reduction 
in p53 protein in SCC-25 eells.
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CHAPTER 1
INTRODUCTION
1.1 Purpose o f the study 
The rate o f occurrence of head and neck squamous cell carcinomas (HNSCC) 
“account for about 13,000 of all cancer deaths” in the United States (Cancer Facts and 
Figures 2004). Currently, combination therapy, drug treatments followed by radiation 
elicit higher survival rates and more effective in preserving of organs in the body than 
other cancer treatment (Kies et al., 2001; Yokes et al., 2003). This treatment option cure 
rate is higher than the cure rate for the well known traditional method o f treating head 
and neck cancer using surgery with radiation therapy. Treatment of local and regional 
head and neck squamous cell carcinoma, in combination with therapy using drugs like 
fluorouracil, paclitaxel and hydroxyurea with radiation control local and regional head 
and neck cancer better than either radiation alone or drugs (Kies et al., 2001; Yokes et al., 
2003). Though chemo-radiotherapy showed a better cure rates for treating this type of 
cancer with increased survival than other forms o f therapy, the drugs commonly tested 
were toxic to the body causing low level o f white blood cells (i.e. leucopenia and 
thrombocytopenia) (Kies et al., 2001; Yokes et al., 2003). Therefore, there is need to 
develop new agents that will be less toxic to the body and increase survival rates (Kies et 
al., 2001; Yokes et al., 2003).
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The naturally occurring plant monoterpenes are constituents o f many fruits and 
vegetables commonly consumed by humans namely, oranges, spearmint, cherries and 
others (Alonso et al., 1992; Kjonaas and Croteau, 1983). The monoterpenes, limonene 
and perillyl alcohol (POH), were reported to elicit anticarcinogenic effects in a number 
o f animal smdies (Elegbede et al., 1984, 1986, and1993) and are currently undergoing 
clinical trials in the US and Britain (Ripple et al., 2000; Murren et al., 2002; Chow et al., 
2002). Pharmacokinetic studies of POH in humans revealed that the major eireulating 
metabolite is perillic acid (PA) (Ripple et al., 1998; Ripple et al., 2000; Murren et al., 
2002; Chow et al., 2002). This implies that PA may be involved in the meehanism of 
action o f POH. The goal o f this research is to investigate if  PA will sensitize head and 
neck cancer eells to radiation effeets when used in eombination ehemo-radiation 
treatment in vitro.
1.2 Research questions 
The mechanism of action of the monoterpenes has not been fully established, it has 
been reported that monoterpenes are involved in regulation of some cellular activities in 
cell growth, including the up-regulation o f mannose-6-phosphate/insulin-like growth 
factor II receptors (Jirtle et al., 1993), increased tissue growth factor receptors (Jirtle et 
al., 1993) and the inhibition of prénylation of small GTP-binding proteins (Crowell et al., 
1991; Kawata et al., 1994). Other reported activities include the induction of phase I and 
phase II detoxification enzymes (Elegbede et al., 2002), expression of Bak and 
programmed cell death via apoptosis (Stayrook et al., 1997). This research work will
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
elucidate the possible mechanism of action of PA as a radio-sensitizer o f HNSCC cells in 
culture. This work will attempt to answer some of the following research questions;
i) Will PA sensitize head and neck cancer cells to radiation in chemo-radiation
treatment?
ii) Will PA cause cell cycle arrest?
iii) Will the radio-sensitization effect of PA be due to cell death via apoptosis?
iv) Will PA affect the expression of p53 protein levels?
1.3 Significance o f the study 
For many years research has been done on the risk factors associated with cancer and 
on factors possibly associated with the prevention of caneer development. The 
identification o f possible agents commonly found in the food we eat that may be helpful 
in preventing cancers shows great promise (Hakim et al., 2000). Progress in HNSCC 
treatments has involved combination therapies that include naturally occurring substances 
in foods. Treatment o f HNSCC using drug alone was reported to minimally increase the 
response rate. However, due to low rates o f survival and high levels of toxicity with the 
common chemotherapeutic drugs and low cure rates with traditional methods (Landis et 
al., 1998), efforts have been redirected at the use o f drugs that are less toxic in 
combination with radiation to produce better cure rates (Rajesh et al., 2003). Synthetic 
drugs SUCH AS fluorouracil, hydroxyurea or paclitaxel are generally very toxic which 
underlies the necessity for developing newer agents that are less toxic for chemo- 
radiotherapy (Yokes et al., 2003). Since monoterpenes are found naturally in plants 
commonly consumed by humans, are less toxic to the body they have the potential to
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
serve as radio-sensitizers in the combination chemo-radiation treatment o f HNSCC cells 
in vitro. Since there is no information in the treatment o f HNSCC using PA in 
combination with radiation, this research will broaden our knowledge regarding the effect 
o f PA as a new agent with less toxicity in the treatment of HNSCC in chemo-radiation 
treatment in vitro and possible mechanism of inhibition.
1.4 Hypothesis
Since PA is found to be the major circulating plasma metabolite in humans after the 
administration o f POH, we therefore hypothesized that PA may be affecting cancer cell 
cycles, thereby sensitizing the cells to irradiation effect. To test this hypothesis, we 
proposed to investigate and confirm that pretreatment o f head and neck cancer cells with 
PA will sensitize the cells to radiation effects.
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CHAPTER 2
LITERATURE REVIEW 
Another group o f plant compounds that received attention as chemopreventive agents 
in caneer therapies are the monoterpenes. Monoterpenes are naturally occurring 
nonnutritive plant compounds that are synthesized via the mevalonate pathway in plants 
(Chayet et al., 1977). These compounds function physiologically in plants as 
chemorepellents and chemoattractants against insects and exhibit distinctive fragrances 
observed in many plants (as reviewed by McGarvey and Croteau 1995). d-limonene 
(Fig. I, p.7), the parent monoterpene synthesized through the mevalonate pathway serves 
as the precursor for the synthesis o f other oxygenated monoterpenes including perillyl 
alcohol, POH (Fig.I, p.7), menthol, perillyladehyde, and carveol (as review by McGarvey 
and Croteau 1995). D-limonene and POH are the two naturally occurring monoterpenes 
(Fig.l, p.7) found in the essential oils of citrus fruits as well as caraway, lavender, 
spearmint and cherries (Alonso et al., 1992; Kjonaas and Croteau, 1983).
Food commonly consumed by humans contains a large variety o f compounds that 
either serve as blocking or suppressing agents in the inhibition of tumors in the body 
(Wattenberg, 1983 and 1985). These are often plant compounds (carotenes, phenols, 
methylated flavones and plant sterols) which may either have preventive or blocking 
activity against cancer. One of the earliest studies o f this kind was reported by 
Wattenberg (1983). Wattenberg studied the blocking effects o f some green coffee beans
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
compounds on neoplasia. One basic role o f blocking agents is the ability to induce phase 
I and phase II detoxification enzymes in the liver that prevent toxicity and tumor 
development. Induction o f glutathione S-transferase activity is being used as a measure 
for determination o f blocking effect o f kahweol palmitate and cafesol palmitate isolated 
in the green coffee beans. Wattenberg's group used rats induced with the chemical 
carcinogen 7,12-dimethylbenz(a)anthracene and found that kahweol palmitate and 
eafesol palmitate obtained from theses coffee beans inereased the aetivity of glutathione 
S-transferase which led to inhibition o f mammary neoplasia (Wattenberg, 1983).
Monoterpenes effects on human skin squamous cell earcinomas have been recently 
studied. Hakim et al. (2000) condueted a cohort study in an Arizona population 
commonly known for growing and consuming fresh citrus fruits. They compared the 
history of squamous cell earcinoma o f the skin and citrus consumption in the population 
using a questionnaire for assessment of eitms consumption prepared with citrus pulp and 
peels supplemented as food among the participants. The predominant types o f citrus 
prepared in this cohort study were grapefruits, orange and orange juice with grapefruit 
having the highest percentage. Based on their findings there was no positive 
“association” between eitrus consumption and squamous cell carcinoma of the skin in the 
subjects (Hakim et al., 2000). However, the level of citrus peel intake and SCC was 
found to be significant due to the high concentration of limonene found in citrus peel 
compared with other citrus content which has low concentration o f d-limonene (Hakim et 
al., 2000).
In rat, Crowell (1992) reported the systematic availability o f the metabolites perillic 
acid (PA) and dihydroperillic acid, (DHPA) (Fig.l, p.7) after administration of d-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
limonene. Further study was done in vitro on the inhibition effect o f PA, on a murine 
fibroblast cell line (NIH3T3). Rats were fed Ig limonene per kg body weight in com 
oil. The rats were sacrificed through ether inhalation while blood and tissue samples 
were collected for analyses of limonene, PA and DHPA. The levels o f limonene, PA and 
DHPA were detected using gas chromatography at low concentrations in samples 
collected after 1 hr o f feeding, i.e., in lung (0.48pmol/g), semm (0.62pmol/g) and in 
kidney (1.09pmol/g). In contrast, higher concentrations were found in adipose 
(2.14pmol/g) and mammary gland tissues (l.lOpmol/g) (Crowell et al., 1992). 
Comparison o f the effects of limonene or PA on cell proliferation of murine fibroblast 
cells showed that PA is more effective than limonene after 4 days exposures while 
limonene minimally inhibited the viability o f cells while 3 mM PA caused complete 
inhibition o f cell growth (Crowell et al., 1992).
OH O OH
(-)-Limonene (-)-Perillyl alcohol
Figure 1 Stmctures o f the monoterpenes.
(-)-Perillic acid Dihydroperillic acid
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2.2 Chemopreventive activities of monoterpenes
Monoterpenes have been reported to possess either blocking or suppressing effects 
against many different cancer models. In 1994, using orange peel oil containing about 
90-95% d-limonene, Crowell et al used fasting men and women (23-55 yr) and were 
asked to refrain from taking citrus fruits or soft drinks for a period of 48 hr. Each person 
was givenlOOmg per kg d-limonene in a semisolid custard-like food containing 5% 
orange. Blood was then drawn from each subject before and twice ingestion after 4 and 
24 h. The level o f toxicity o f the plasma metabolites was monitored in all participants 
using capillary gas chromatography. After 4 hr post-ingestion the level o f PA (35pM) 
was predominant, followed by DHPA (33pM) and limonene-2-ol (16pM) after 4 hr post­
ingestion (Crowell et al., 1994b). No intrasubject change in d-limonene and metabolites 
was observed in samples analyzed after the intake o f limonene but four out o f the seven 
participants suffered from mild eructation while others reported mild satiety and slight 
fatigue (Crowell et al., 1994b).
In 1984, Elegbede et al. determined the effects of d-limonene in rats fed for a week 
before induction o f tumor by DMB A. When rats were treated with limonene for one 
week and subsequently treated with DMBA for a period of 27 weeks it caused a decrease 
in mammary tumor development compared to the control groups (Elegbede et al., 1984). 
Elegbede et al. (1986) studied the effects o f orange oil and d-limonene in mouse skin 
tumors in two-stage skin carcinogenesis induced by 7, 12-dimethylbenza[a]-anthracene 
(DMBA) given in 0.2 ml o f acetone. The control group received 0.2 ml acetone while 
the orange oil and d-limonene were administered topically or by dietary intake. Testing 
started on the 7* day and lasted for another one-week period in which the tropically
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
tested mice were treated with 12-0-tetradecanoylphorbitol-13-acetate (TPA), orange oil 
and d-limonene all in acetone mixture. Before the 10* week post-initiation, they weight 
the treated animals and during the initial 4 weeks, they monitored the diet intake and 
observed that no palpillomas developed in the treated mice given either orange oil or d- 
limonene after initiation with DMBA. In animals that were induced with DMBA 
followed by TP A, the rate o f papilloma development was observed to be higher than their 
first observations and that high rate o f papilloma occurrence was result o f the 
effectiveness o f orange oil compared to d-limonene (Elegbede et al., 1986). In another 
study using 3 day old female Wistar-Furth rats Elegbede et al (1993), used limonene 
(5%) and sorbrerol (1%) to study the blocking effect when DMBA is used to initiates 
carcinogenesis. The liver enzymes glutathione transferase (GST) and uridine 
diphosphoglucuronosyl transferase (UDPGT) fimction in the liver to prevent carcinogen 
interaction with DNA. They used the level o f detoxification enzymes to measure the 
effectiveness o f limonene intake. Both the limonene and sobrerol were reported to 
increase the activity o f GST and UDPGT in rat livers (Elegbede et al., 1993). Another 
observation was that both limonene and/or sorbrerol diets significantly (P<0.05) caused 
the level o f non-protein sulfhydryls to be elevated compared to the glutathione levels 
observed earlier (Elegbede et al., 1993).
To further elucidate the chemopreventive activities o f monoterpenes Haag and Gould 
(1994) used 70 Wistar-Furth rats to investigate the preventive effect of administering 
POH on rats given DMBA to initiate papilloma development. “Complete regression was 
defined as the nonpalpability of the tumor for 3 weeks. Partial regression was defined as 
half or less o f the original diameter of the tumor induced via DMBA that was palpable”
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(Haag and Gould 1994). After first mammary tumor induction, 2.5% POH caused a 
complete regression of the tumor in 22 out of 27 rats after 3 weeks compared to control 
group which had only 9 out o f 29 showing complete tumor regressions (Haag and Gould
1994). In a second study using 215 rats treated with chemical carcinogen DMBA, they 
also reported that 1% POH only showed significant level of tumor regression and the 
redifferentiation o f tumor cells observed may have been the POH administered (Haag and 
Gould, 1994).
Mills et al. (1995) used Fischer 344 rats treated with diethylnitrosamine (DEN) to 
investigate the effect o f POH on carcinogenesis. After 19 weeks o f daily replacing the 
POH, they found out that the mean liver tumor weights o f the rats treated with POH were 
about 10-fold less compared with control animals. To elucidate the possible means of 
action in the liver tumor, they confirmed that POH induced apoptosis, caused increased 
levels of manaose-6 phosphate/insulin growth factor and transforming growth factor p 
type I, II and III receptors in all the treated groups (Mills et al., 1995).
2.3 Biosynthesis of monoterpene from mevalonate pathway
There are two distinct pathways that plants used for the biosynthesis of 
monoterpenes. One pathway involves the condensation reaction occurring in the cytosol 
o f two acetyl-CoA via the mevalonate pathways to form isopentenylpyrophosphate (IPP) 
which is the precursor o f isoprenoids. The other pathway occurs in the plant plastid 
involves the condensation of pyruvate and D-glyceraldehyde-3-phosphate catalyzed to 
yield IPP. This reaction is catalyzed by a transferase (as reviewed by McGarvey and 
Croteau, 1995).
10
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
o o
CoA + H.C
CoA ACETYL-CoA
O O
^CoASH
H3C H2C
CoA O ACETOACETYL CoA
CoA
CoASH
O
O H,C
OH O
/ Hz2'- / ^ 2'-' c
H3C
6-HYDROXY-6-METHYLGLUTARYL CoA 
CoA (HMG-CoA)
r
o  OH
2NADPH + 2H
^2N A D P
+
COASH
O H,C /  H,C
H2
- % .
MEVALONATE
H3C
2'- OH 
ATP
O OH ''
xADP
O
/ S
°  H2C /  H2C Nq /  \ 5-p h o s p h o m e v a l o n a t e
H3C
Figure 2. Synthesis o f 5-phosphomevalonate from the condensation o f two acetyl-CoA 
units via the mevalonate pathway (Adapted from McGarvey, D. J. and Croteau, R. 1995).
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Figure 4. Cyclization o f geranyl pyrophosphate to form the naturally occurring 
monoterpenes limonene and perillyl alcohol (Adapted from McGarvey, D. J. and 
Croteau, R. 1995).
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The synthesis o f monoterpenes starts with the condensation reaction o f two acetyl- 
CoA units catalyzed by acetyl-CoA acetyltransferase to form acetoacetyl-CoA (Goldstein 
and Brown, 1990). The HMG-CoA synthase catalyzed the next reaction involving the 
addition of another acetyl-CoA unit to form P-hydroxyl-|3-methylglutaryl-CoA (HMG- 
CoA) (Fig.2, p .l 1). The next step which is “a rate limiting step in cholesterol 
biosynthesis in animals” (as reviewed by McGarvey and Croteau, 1995), the HMG-CoA 
undergoes a reduction reaction in the presence o f NADPH catalyzed by HMG-CoA 
reductase to form mevalonate (Fig.2, p .l 1). Mevalonate is then phosphorylated by the 
kinase enzyme called mevalonate kinase to form 5-phosphomevalonate which undergoes 
another phosphorylation reaction catalyzed by phosphomevalonate kinase, to form 5- 
pyrophosphomevalonate (Fig.2, p .l 1). This compound is further decarboxylated by the 
action o f pyrophosphomevalonate decarboxylase to form isopentenylpyrophosphate, IPP 
(Fig.3, p. 12) (as reviewed by McGarvey and Croteau, 1995). The IPP is polymerized 
with its isomer 3, 3-dimethylallyl diphosphate by prenyltransferases to form the 
monoterpene precursor geranylpyrophosphate (GPP) (Fig.3, p .12). Limonene synthase 
catalyzes the cyclization of geranylpyrophosphate via a dephosphorylation reaction to 
form limonene (Fig.4, p. 13). Limonene is catalyzed by limonene 7-monooxygenase to 
form perillyl alcohol (oxygenated hydroxyl product) in the presence of NADPH (Fig.4,
P 13).
2.4 Mechanism of action 
Chemopreventive agents may have either cancer blocking or suppressing activity 
against different types o f tumors (Wattenberg 1983 and 1985). Blocking effects occurred
14
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during the initiation phase of carcinogenesis to prevent the interaction of the chemical 
carcinogens with DNA via modulating carcinogen metabolism to less toxic forms later 
eliminated in the body. The suppressing chemopreventive agents act differently by 
preventing the development o f initiated cells during the promotion phase of 
carcinogenesis (Wattenberg, 1985). The mechanism of tumor regression by 
monoterpenes still remains unclear but several cellular activities have been reported to be 
related with monoterpenes. These mechanisms are thought to include induction of cell 
cycle arrest or blocking of the Gi phase, programmed cell death via apoptosis (Shi et al., 
1997) and activation o f phase I and phase II detoxification enzymes (Matlzman et al., 
1991; Austin et al., 1988). Other effects include the inhibition of the post-translational 
modification of the covalent attachment of famesyl or geranylgeranyl groups to the 
carboxylic terminus o f GTP-binding proteins involved in signal transduction (Clarke et 
al., 1992; Crowell et al., 1994). Elegbede et al. (2003), using human carcinoma cell lines 
(BroTo and A549), reported the effect o f POH and perillaldehyde (PALD) administered 
in vitro for 12 to 24 hr. POH or PALD caused a dose-dependent inhibition of cell growth 
on BroTo and A549 cells (Elegbede et al., 2003). They found that 1.0 and 1.2 mM POH 
caused 50% inhibition in BroTo and A549 cells while concentration o f 3.2 and 3.0 mM 
for PALD was reported after 24 hr (Elegbede et al., 2003). The mode o f cell death was 
via apoptosis when cells were treated with POH, while PALD related cell death was 
thought to be through a possible pathway that is yet unknown (Elegbede et al., 2003).
The effect o f POH was reported to be protective against colon cancer and other types of 
cancers by induction of the detoxification enzymes in liver (Maltzman et al., 1991). They
15
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reported that 5% limonene diet increases the activities o f cytochrome p450 family 
members and epoxide hydratase (Maltzman et ah, 1991).
Reddy et al. (1997) studied the effect o f POH on rats induced with the carcinogen 
azoxymethane (AOM). They treated rats with AOM after being fed either POH/kg body 
weight or saline for two weeks and the rats remain on POH or the vehicle for 55 weeks. 
The percentage o f control rats with invasive colon adenocarcinomas was observed to be 
greater than the treated group (Reddy et al., 1997). Another observation found was that 
the rate of occurrence and diversity o f noninvasive colon adenocarcinomas in these rats 
was unaffected (Reddy et al., 1997). For some unknown reason, they discovered that the 
2g POH diet significantly (p<0.001) inhibited the incidence of total colon 
adenocarcinomas and small intestinal adenocarcinoma (Reddy et al., 1997). However, 
the apoptotic index was increased by about 5 to 6-fold when rats were given either I go r  
2g POH per body weight diet compared to the control groups (Reddy et al., 1997).
Stayrook et al. (1997) studied the treatment of malignant hamster pancreatic ductal 
epithelial cells and nonmalignant hamster pancreatic ductal epithelial cells with 
thymidine incorporation o f POH. From the data acquired, POH caused apoptosis in 
malignant cells treated with varying concentrations of POH. The increase in the 
apoptotic populations increased proportionately with increase concentration o f POH 
causing higher rates of apoptosis (Stayrook et al., 1997). The population of cells that 
undergo apoptosis in nonmalignant cells was minimal compared to the malignant cells 
and POH also caused a two-fold increase in Bak expression in malignant hamster 
pancreatic ductal epithelial cells while its expression remained unaltered in non­
malignant cells (Stayrook et al., 1997).
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Several human clinical trials conducted have revealed that PA is the most abundant 
circulating plasma metabolite followed by DHPA after administration o f POH in humans 
(Ripple et al., 1998; Ripple et al., 2000; Murren et al., 2002). Ripple et al. (2000) 
conducted a phase I clinical trial of POH administered to subjects with incidence of 
advanced refractory malignancies. The administration of POH to these subjects was done 
four times per day in a continuous manner at 3 different doses of SOOmg/m^, 1200mg/m^ 
and 1600mg/ m^. They administered POH to subjects in soft gelatin capsules containing 
250mg o f POH and 250mg of soya bean oil. They observed an increased in the levels of 
PA and DHPA in the plasma to occur at 1-2.5 hr and 2-3.5 hr respectively after post­
ingestion of POH (Ripple et al., 2000). The level of plasma metabolite as reported in 
their work of 1998 for PA was found to be predominant than DHPA (Ripple et al., 2000). 
After 29 days o f POH administration, they noticed that the level o f PA or DHPA in the 
plasma was decreasing with time and the maximum tolerated dose o f POH to be 1200mg/ 
m^ (Ripple et al., 2000). Chow et al. (2002) using healthy individuals to determine the 
systemic availability of PA when administered with a single dose of Mediterranean-style 
lemonade rich in limonene. They started taking blood samples from subjects before 
given them light breakfast containing limonene in the form of Mediterranean-style 
lemonade over a time period of 10-20 minutes. Blood samples after completion o f the 
lemonade intake, were again drawn at different time points and analyzed the level of 
limonene in juice and plasma level o f PA. Rapid increased in the plasma level o f PA 
after 1 hr consumption was observed and declined rapidly as a function o f time with the 
half life o f PA ranging from 0.82 to 1.84 hr (Chow et al., 2002). PA levels were 
undetected after 24 hr in all the samples collected (Chow et al., 2002). Brown et al.
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(2000) investigated the effects of epidermal growth factor receptor (EGFR) in 
combination with either cisplatin or 5-fluorouracil (5-FU) on the growth rate o f human 
squamous cell carcinoma (SCC) SCC-25 and BroTo cell lines in vitro. They reported 
that EGFR are found on the surface o f many different tumor cell lines with IgG 
monoclonal antibodies (Mabs). When they treated the cells with cisplatin or 5-FU and 
then exposed to different concentrations o f epidermal growth factor receptor (EGFR 
Mab), the cell growth of SCC-25 cells was significantly (p < 0.001) decrease compared to 
the cells treated with cisplatin alone (Brown et al., 2000). They also reported that both 
BroTo and SCC-25 showed significant inhibition with EGFR Mab and 5-FU compared 
with 5-FU alone (Brown et al., 2000).
In a study to determine the possible involvement of PA in cell proliferation, Ferri et 
al. (2001) investigated the possible mode of action o f PA on rat arterial smooth muscle 
cells (SMC). When cells were treated with 1- 3mM concentrations of PA for up to 72 hr, 
PA caused a time- and concentration-dependent inhibition of SMC cells and a decrease in 
cholesterol biosynthesis in the cells. The incorporation o f mevalonate, femesol or 
geranylgeraniol did not influence the inhibition effect exerted by PA (Ferri et al., 2001). 
To find out whether the prenyl transferases are the possible target for PA, the 
incorporation o f radiolabelled famesol or geranylgeraniol into the cellular proteins was 
blocked by PA in the cells. With this result, their concluded was that PA inhibits cell 
growth via prevention of prénylation of proteins in the SMC cells and the concentrations 
o f PA (l-3mM ) that significantly (p<0.01) inhibited SMC cell growth was in correlation 
with 0.47 mM plasma concentration that was achieved by Ripples et al. 2000 (p.88) in 
their clinical studies using POH on patients with malignancy (Ferri et al., 2001).
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2.4 Combination chemoradiotherapy 
It was reported that the sensitivity o f radiation exposure on cell growth in different 
types o f cancer cells is dependent on which phase of the cell cycle the cells are and the 
effect o f radiation sensitivity can be improved when used in combination with other 
chemotherapeutic agents (Rotman and Aziz 1998). In 1993, Gordon and his group 
reported that many chemotherapeutic agents may stop the repair of radiation damage by 
cancer cells which implies the possibility o f synergistic or additive action between 
chemotherapeutic agent and radiation when used in combination chemo-radiation therapy 
(Gordon et al., 1993). Combination treatment using drugs and radiation has been tested in 
clinical practice in malignant tumors (Rotman and Aziz 1998 and Yokes et al., 2000). 
Many randomized clinical trials were performed with drugs and radiation which indicated 
that certain chemotherapeutic agents have the ability to inhibit radiation resistance seen in 
other types o f cancer cells thereby improving sensitization to radiation effect (Kim et al., 
2000).
Kies et al., (2001) studied the use of combining drug and radiation in the treatment of 
head and neck cancer and reported that the intense radiation exposure and chemotherapy 
drugs, when delivered together in concurrent combination treatment was highly 
successful at controlling the local spread o f head and neck cancer in subjects with this 
advanced disease (Kies et al., 2001). They reported that when they combined the known 
chemotherapeutic drugs (paclitaxel, fluorouracil and hydroxyurea) with a prolonged 
twice daily radiation treatment, the outcome was a successful management of the local 
and regional spread o f head and neck cancer in about 90% of the patients (Kies et al., 
2001). The overall survival rate of 55% observed at three years, which they said was
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encouraging, but the treatment could not prevent distant metastasis which occurs in 20% 
of patients (Kies et ah, 2001). Even though they maintained that the study was an 
improvement in treatment o f head and neck cancer, the particular drugs used were too 
toxic to the patients which led to death of other patients. In all the subjects used for this 
studied, 81% was reported to experience temporary severe drops in white blood cells and 
platelets, which is common with chemotherapy and a severe constrained to eat normally 
for at least a year (Kies et ah, 2001).
In a current study by Yokes et ah, (2003) combination chemo-radiation therapy was 
performed with patients with stage lY head and neck cancer. They administered 6 doses 
o f carboplatin and paclitaxel weekly followed by twice daily radiation dose at 1.50 Gy 
per fraction for 5 cycles. They observed high response rate and reduction in distant 
failures rates among the subjects (Yokes et ah, 2003) and concluded that a treatment 
approach which caused high survival rates and progression with preservation o f organ in 
a population o f stage lY patients with advanced locoregionally carcinoma o f the head and 
neck cancer has been elucidated (Yokes et ah, 2003). A phase II trial was carried out 
using chemoradiotherapy in order to achieve locoregional control of head and neck 
cancer with high survival rate and preservation of organ. Patients were treated with 
cisplatin administered every 28 days, followed by 5 days infusional fluorouracil and 12 hr 
oral administration o f hydroxyurea for 11 doses before 5 days twice daily radiation 
exposure at 1.5 Gy per fraction. Subjects with locoregional advanced stage lY of the head 
and neck cancer were selected specially those with cancer of the larynx, oral cavity, 
paranasal sinuses, cervical esophagus and pharynx. It was reported that treatment using 
chemo-radiotherapy results in a locoregional control rate that exceeds 90% among the
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subjects (Yokes et al., 2003). Their conclusion was that using agent that are less toxic to 
subjects in combination therapy, toxicity can be avoided when used in future studies and, 
possibly, radiation protective agents (Yokes et al., 2003).
The HNSCC account “for approximately 45,000 new cases and 13,000 deaths per 
year in United States” (Cancer Facts and Figures 2004). Most o f these cancers begin in 
the oral cavity and the traditional treatment option for locally advanced HNSCC is 
surgery followed by intensive radiation regimen. However, these treatment modalities 
are associated with high morbidity with low survival rates (Stupp et al., 1987). “The way 
a particular head and neck cancer response to any treatment options depends on the 
primary site o f occurrence in the body. For instance, cancers that initiate on the vocal 
cords behave in a differently manner than do those that arise in the larynx indicating 
different response rates” (Al-Sarraf M., 1988; Landis et al., 1998). Squamous cell 
carcinoma is the most common type of head and neck cancer which arises in the cells that 
line the inside o f the oral cavity, throat and nose. The uncommon types o f head and neck 
cancers include sarcomas salivary gland tumors and lymphomas (Landis et al., 1998).
The three main types o f treatment options for head and neck cancer was reported to 
include radiotherapy, surgery and chemotherapy. The primary treatment option for head 
and neck cancer are radiation therapy or surgery, or combination o f the two; with 
chemotherapy sometimes used as an adjuvant (Landis et al., 1998). The best treatment 
option for a particular head and neck cancer depends on the time of diagnosis, site of 
incidense and the extent o f the tumor developed (Landis et al., 1998). Recent findings in 
using drugs and radiation indicate that combination of chemotherapy given at the same
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time with radiation therapy exhibited a more effective treatment option with higher 
survival rates than either single traditional treatment modality (Yokes et al., 2003).
Rajesh et al., (2003a) first tested the importance of POH as sensitizer in radio- and 
chemo-sensitization treatment using malignant glioma cell lines. Concentration of 
0.5mM POH and 5.5 Gy dose o f radiation were used in combination treatment on glioma 
cells to test the effect o f pretreatment o f POH as radio-sensitizer. They pretreated cells 
with POH at intervals o f 2 and 24 hr and then irradiated the cells with 5.5 Gy and the 
cells were immediately replated for 2 weeks in tissue culture plate with fresh medium. 
After incubation, the earliest onset o f radio-sensitization by POH was observed after 8 hr 
of treatment (Rajesh et al., 2003a). Cell cycle analysis on glioma cell line (T98G) treated 
with POH caused a dose and time-dependent increase in suh-Go/Gi cell population and a 
block at G2/M phase o f the cell cycle (Rajesh et al., 2003a). Cells treated with 1 mM 
POH exhibited increased in early apoptotic population positive for AnnexinY only. Their 
data indicated that apoptosis and radio-sensitization o f glioma cells by POH was via the 
expression o f Fas ligand and Fas receptor (Rajesh et al., 2003a). In another study, Rajesh 
et al. (2003b) using prostate cancer cells, cells were treated with 0.1-0.5 mM POH for a 
period of 72 hr and then exposed to different doses o f radiation. They observed a 
significant reduction o f the cell growth in DU 145 and PC-3 cells when treated with 
concentrations between 0.7 and 1 mM POH (Rajesh et ah, 2003). Pretreatment o f these 
cells with POH also elicited a dose- and time-dependent sensitization o f the prostate 
cancer cells to radiation (Rajesh et al 2003b). The authors then treated DU 145 and PC-3 
cells with POH for 72 hr in the presence and absence of 5.5 Gy dose of radiation. They 
reported an increase in the population of cells in sub-Go/Gi and early apoptotic cells
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positive for Annexin V (Rajesh et al., 2003b). They also reported an increase in the 
G2/M phase and a decrease in the Gq/Gi phase o f the cell cycle which appeared to 
precede the onset of apoptosis in both DU 145 and PC-3 (Rajesh et al., 2003b). Treatment 
with POH also caused an increased expression of cyclin D1 (Rajesh et al., 2003b). One 
interesting finding was that POH did not alter the level o f Fas receptor expression in all 
the prostrate cancer cells (Rajesh et al., 2003b).
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CHAPTER 3
MATERIALS AND METHODS
3.1 Chemicals and reagents 
Perillyl alcohol (4-isopropenyl-cyclohexenecarbinol) and perillic acid (4-isoprepenyl- 
I-cyclohexene-1- carboxylic acid) were procured from Aldrich Chemical Co. 
(Milwaukee, WI). Phosphate buffered saline (PBS; lacking Ca^^ and Mg^^), penicillin 
(100 units/ml) and lOOpg/ml streptomycin (P/S) and trypsin-EDTA were purchased from 
Invitrogen Corporation (Grand Island, NY). AlamarBlue dye was obtained from 
Biosource Intl. Inc. (Camarillo, CA). Propidium iodide (PI) and ribonuclease A (RNase 
A) were obtained from Sigma Chemicals (St. Louis, MO). Fetal bovine serum was 
purchased from HyClone Laboratories (Logan, UT). DMEM/F-I2, RPMI and MEM-a 
media were purchased from Invitrogen Corporation (Grand Island, NY). Standard 
diluent buffer (contains 15 mM sodium azide), p53 standard, rabbit anti-p53 (detection 
antibody containing 15 mM sodium azide), anti-rabbit IgG-Horseradish peroxidase 
(HRP) containing 3.3 mM thymol, HRP diluent (contains 3.3 mM thymol, wash buffer 
concentrate (25x), stabilized chromogen (tetramethylbenzidine) and stop solution were 
procured from BioSource hitemational Inc. (California, USA). BCA protein assay 
reagent kit was obtained from Pierce (Rockford, IL).
24
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3.2 Cells and cell culture
Human squamous cell carcinoma of the tongue, SCC-25 procured (ATCC Rockville, 
MD), BroTo (a gift from J. Truelson, MD, Department o f Otolaryngology, University of 
Texas, South-western Medical Center) and human squamous cell carcinoma of the 
pharynx HTB-43 (ATCC Rockville, MD) were used in these studies. T-Lymphocytes 
cells, Jurkat cells (a gift from Dr. S. Carper), was also used as control cell line for 
Annexin-V flow cytometry. Cells were cultured in DMEM/F-12 (SCC-25), RPMI 
(BroTo), MEM-a (HTB-43) or RPMI 1640 (Jurkat) supplemented with 10% FBS and 1% 
P/S. Cells were dislodged with trypsin-EDTA and the indicated numbers o f cells were 
plated in tissue culture plates and allowed to adhere overnight. Stock (IM ) solutions o f 
POH and PA were prepared by dissolving each agent in dimethyl sulfoxide (DMSO). 
Treatment media were prepared by diluting the stock solution in medium to give the 
desired concentration and allowed to solubilize at 37*̂ C for 1 hr with occasional mixing. 
Cells in the control groups received medium containing DMSO. Cells treated with 
various concentration of each agent were incubated in humidified, 5% CO2 atmosphere at 
37°C.
3.3 Dye-exclusion assay
Two million cells were cultured in each of 100mm tissue culture plates and allowed 
to adhere overnight. Cells were then treated with varying concentrations o f agents for 72 
hr. Control cells received medium with DMSO (<0.I%; v/v) only. Control, PA- and 
POH-treated groups were exposed to I Gy or 2Gy dose of irradiation source (X-ray, 6MV 
Varian Clinacl/100 Palto Alto, CA) and were incubated overnight at 37°C in humidified 
5% CO2 atmosphere. Cells were harvested with trypsin-EDTA and centrifuged at 840
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rpm (Allegra™ 6KR Centrifuge, Palo Alto, CA). Live cells were counted on a 
hemocytometer. The effect of different treatments on cell proliferation was measured by 
directly counting the number o f live cells that excluded trypan blue dye.
3.4 Mitochondrial dehydrogenase assay 
A modified method for the determination o f mitochondrial dehydrogenase activity in 
live cells was used according to the manufacturer’s instruction. The alamarBlue assay 
incorporates the REDOX indicators that both fluoresce and change color (fi-om blue to 
red) due to the chemical reduction o f the growth medium resulting from cell proliferation 
(Fields and Lancaster 1993.). Cells (5000 cells/well) were plated in 96-well plates and 
allowed to adhere overnight. The following day, the culture medium was replaced with 
medium (100 pi) containing the desired concentration o f POH or PA and incubated at 
37°C in humidified CO2 atmosphere for 24, 48 or 72 hr. At the end of the exposure 
period, the treatment medium was replaced with lOOpl o f fi-esh medium and lOpl o f the 
alamarBlue dye in each well and the cells incubated at 37°C in 5% CO2 atmosphere for at 
least 4hr. Fluorescence was measured after excitation at 530nm wavelength and emission 
at 590nm wavelength using GENios fluorescence plate reader (PHENIX Research 
Product, Hayward, CA). Cytotoxicity was assessed by comparing the fluorescence 
intensity data from calculating the viable cells in the treatment group relative to the 
control groups (100%).
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3.5 Clonogenic assay 
Cells (2 X 10^) cultured overnight in 100mm tissue culture plate were similarly treated 
with or without 1.0 mM PA or 0.5 mM POH for 72 hr and exposed to IGy or 2Gy doses 
o f radiation as described earlier (p.25) and clonogenic or colony formation assay (CFA) 
was performed as described by Elegbede et al. 2003 (see Ref. 17, p.84) to determine the 
long-term effects o f the monoterpenes on the proliferation of cancer cells. Cells were 
washed twice with sterile PBS and the complete culture medium after incubation. Cells 
(500/well) were then cultured in 6-well tissue culture plates. Fresh, complete culture 
medium was then added to each well and the cells were incubated for 10-14 days at 37°C 
in humidified, 5% CO2 atmosphere. Cells were observed every other day to monitor cell 
growth. At termination, the culture medium was removed, the cells were rinsed with 
PBS, stained with crystal violet (5mg/ml in 95% ethanol) and the dye gently rinsed off 
and allowed to dry. Colonies, containing at least 50 cells, were counted in each well and 
the cell viability was calculated as a percentage o f the number of colonies formed in the 
treatment group relative to the control (100%).
3.6 Combination Chemo-irradiation studies 
One thousand cells were plated in 96-well tissue culture plates overnight for cells to 
adhere. The culture medium was replaced with fresh 200pl culture medium. Cells were 
then irradiated with varying doses of X-ray, from 0, 1, 2, 3, 5 and 8Gy (6 MV Varian 
Clinac 1/100, Palto Alto, CA). After radiation, cells were then incubated overnight at 
37°C in humidified 5% CO2 atmosphere. Treatment medium was replaced with fresh 
completes medium (100 pi) and incubated for 5 days before performing alamarBlue assay
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as described earlier (p.26). For effects o f combination treatment, cells were cultured 
either in 100 mm (2 million cells each) or in 6-well (500 cells/well) plates and were 
treated without (control) or with PA or POH. In one set o f experiments, cells were 
exposed to 1 or 2Gy o f X-ray (6 MV Varian Clinac 1/100, Palo Alto, CA) while in the 
other set the cells were not irradiated. Following irradiation, the cells were incubated for 
12 to 15 hr at 37°C in humidified, 5% CO2 atmosphere. All the cells were harvested and 
used for dye exclusion or colony formation assays and cell cycle analysis as described 
(p.26 and p.28).
3.7 Cell cycle analysis 
To determine whether the monoterpenes affect cell cycle or apoptosis, cells (5 x 10  ̂
/well) were cultured in 6-well plate overnight at 37°C in humidified, 5% CO2 atmosphere. 
Cells were then treated with 1.0 mM PA or 0.5 mM POH for 24 hr or 72 hr. After 
incubation (as described by Elegbede et al., 2003, p.85), cells were harvested, fixed in 
90% ethanol and kept at 4°C prior to analysis. For cell cycle analysis, the cells were 
stained with the DNA staining solution (150pg/ml PI, 0.1% Triton X-100, and Img/ml 
RNase A (DNase-free) in PBS, 1:1:1 by volume). The DNA contents o f the control and 
treated cells were measured by flow cytometry following propidium iodide staining using 
a FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA). Twenty thousand 
events were acquired and the proportion of hypodiploid (sub-Go/Gi) events and cells in 
Go/Gi, S and G2/M phases of the cell cycle were determined using the DNA analysis 
software ModFit LT 3.0 (Verity Software House, Topsham, ME).
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3.8 Apoptosis assay
Cells (Ix  10  ̂cells/ plate) were plated overnight and treated with 0.5 mM POH or 1.0 
mM PA for 72 hr. Both control and treated cells were harvested after incubation and 
washed with cold PBS at 400x g for 5 min. Pellets were resuspended in cold PBS and 
counted. According to the manufacturer’s instruction, the numbers o f cells was adjusted 
to approximately 500,000 cells per ml before pelleting at 400x mg for 5 min. Pellets 
were then washed in 2.0 ml x 1 Annexin-V Binding buffer (BD PHARMINGEN, San 
Jose, CA) at 500 x mg for 5 min. The pellets were treated with Annexin-V-FITC 
conjugated (BD PHARMESfGEN, San Jose, CA) and incubated in the dark for 15 min. 
The treated mixture contains 5 pi o f Annexin V conjugated to approximately 500,000 
cells in 1 pi fetal bovine serum. The volume o f cells with Annexin V conjugated mixture 
was then adjusted up with addition o f 450pl o f x 1 Annexin-V binding buffer, (each tube 
contains cells-conjugate mixture of approximately 500pL). Acquisition to discriminate 
between apoptotic and necrotic or dead cells was done by staining the cells-conjugate 
mixture with lOpL PI solution (500pg/ml) (BD PHARMINGEN, San Jose, CA). 
Acquisition was done on BD’s FACS Calibur cytometry on the FLI (Annexin) and FL3 
(PI) channels with threshold on FSC and Duplet Discriminating Module (DDM) set at 
FLI. The level o f shift in events distribution in the treated cells stained with Annexin-V 
only and Annexin-V-PI populations in comparison to untreated controls is indicative of 
degree o f effectiveness of the treatment agent(s). Numeric quantitations of these events 
are accomplished with population gating.
We further visualized apoptotic cells using detection system from Phoenix Flow 
System Inc. according to the manufacturer’s instructions. Cells (HTB-43, SCC-25 or
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Jurkat T-lymphocyte,) were fixed with formaldehyde to retain (crosslink) fragmented 
DNA within apoptotic cells. The 3'OH termini of DNA strand breaks were labeled with 
BrdUTP in the reaction catalyzed by the terminal deoxynucleotidyl transferase (TdT); 
cellular DNA was counterstained with PI and DNA content was measured using 488 nm 
laser excitation in FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA). To 
calculate the percentage of cells in the respective phases of the cell cycle, the DNA 
content frequency histograms were deconvoluted using the MultiCycle software (Phoenix 
Flow Systems, San Diego, CA).
3.9 Cell lysate preparation 
Cells were plated and allowed to stay overnight. The following day, the medium was 
aspirated off and cells were treated with 0.5 mM POH or I.O mM PA for 72 hr. Cells 
were then exposed to IGy or 2Gy dose of irradiation and incubated overnight. Cells were 
harvested and transferred into a 15 ml centrifuge tube. The cells were then centrifuged at 
840 rpm for 5 minutes and media was aspirated off. The pellets were resuspended and 
then washed three times with 5 ml of cold PBS. The pellets were resuspended in 1ml of 
PBS and were transferred into a microfuge tube and then centrifuged at 13,000 rpm 
(BECKMAN Microfuge® R Centrifuge, Palo Alto, CA) for 10 minutes at 4°C and stored 
at -80°C for protein analysis. Cells were thawed and lysed in cell extraction buffer 
(containing protease inhibitor and PMSF) for 30 minutes on ice while vortexing at 10 
minutes interval (according to Pierce BCA protein assay, Rockford, IL). The extracts are 
then transferred into microcentrifuge tubes and centrifuged at 13,000 rpm for 10 minutes 
at 4°C. Aliquoted the clear lysate into clean microcentrifuge tubes and assayed.
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3.10 Determination of p53 protein in HNSCC cells.
The protein concentration o f each sample was determined using BCA protein assay 
according to the manufacturer’s instruction. Different dilutions o f bovine serum albumin 
(BSA) standards were prepared (0, 25, 125, 250, 500, 750, 1000, 1500 and 2000pg/ml) 
and 25 pi each of prepared BSA standards or samples (lOpl of cell lysate and 15pl diluent 
PBS) were then pipetted into 96-well microtiter wells and 200pl of BCA working reagent 
was then added into all wells and incubated for 30 minutes at room temperature and the 
absorbance was measured at 570 nm wavelength using ELISA plate reader. Protein 
concentration o f each sample was then calculated from the absorbance reading. The p53 
protein was determined and quantified using Biosource p53 ELISA according to the 
manufacturers instructions. Standard diluent buffer (100pi) were added to zero wells in 
p53 antibody-coated wells and well(s) reserved for chromagen blank was left empty. 
Standards, samples or controls (100pi) were then pipetted into their appropriate reserved 
wells. The plate was covered and incubated for 2 hr at room temperature. The extracts 
were diluted in cell extraction buffer (5pi sample into 95pi). After incubation, the 
solution was aspirated off from the wells and each well was washed 4 times with wash 
buffer. One hundred microliter o f anti-p53 (detection antibody) solution into each well 
except the chromogen blank(s) and mixed gently. The plates were covered and incubated 
for 1 hr at room temperature. The solution was again aspirated from each well and each 
well washed again 4 times with wash buffer. Anti-rabbit IgG-HRP (lOOpl) working 
solution was transferred into each well except the chromogen blank(s) before incubating 
for 30 minutes at room temperature. Solutions were again aspirated off from the wells 
and washed 4 times with wash buffer. Standard chromogen (100 pi) to each well
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including the chromogen wells and plates were further incubated for 30 minutes at room 
temperature in the dark. The stop solution (100 pi) was then added into to each well and 
mixed gently until solution change from blue to yellow. The absorbance was read on 
GENios plate reader at 450 nm wavelength against a chromogen blank. Absorbance of 
each sample was calculated to quantify the level o f p53 protein (according to 
manufacturer’s instruction using BioSource p53 (Total) ELISA assay).
3.11 Statistical analyses 
Results are expressed as Mean ± SD of replicate analyses. The effectiveness of 
treatment methods and combination treatments were analyzed using ANOVA. Dunnett’s 
two-sided test (at a  = 0.01) was used to evaluate differences in the effects between POH, 
PA and the controls. The effectiveness o f POH compared to control or PA was 
determined by Turkey’s least significant difference (LSD). Differences with p-value less 
than 0.01 (p<0.01) were considered statistically significant. The combination treatment 
act with significant difference (ANOVA at a  =0.01) in each cell line (HTB-43, SCC-25 
and BroTo) and method while both treatment factors (monoterpenes and radiation) are 
significant on the rate o f effectiveness (ANOVA at a  = 0.01). Comparison with control, 
both PA and POH are significantly different from control (Dunnetts two sided test 
a t<2 = 0.01). Comparison of compounds with each other, POH results in the highest rate 
o f effectiveness than PA in all the cell lines (Turkey’s LSD ay «  = O.OI). Comparison of 
radiation, IGy of radiation results in significantly better effectiveness than no radiation in 
combination treatment (ANOVA at «  = 0.01).
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CHAPTER 4
FINDINGS OF THE STUDY
4.1 Analysis of results 
The cytotoxicity effect of PA and POH was determined by alamarBlue assay in 
HNSCC cells exposed for 24, 48 and 72 hr time point. Treatment with 1.0 mM PA and 
0.5 mM POH caused a dose- and time-dependent inhibition with greater effect observed 
after 72 hr on HTB-43 (19% and 51%), SCC-25 (24% and 63%) and BroTo (31% and 
40%) cells respectively (Fig. 5, p.38)
To determine the effect of radiation on cell proliferation, cells were exposed to 
numerous dose o f radiation from IGy to 8Gy. A dose dependent inhibition on cell 
proliferation was observed with IGy as follows: HTB-43 (20%)>SCC-25 (8%)>BroTo 
(5%) respectively (Fig. 6, p.39). Drastic inhibition was seen with 8Gy dose (Fig.6, p.39).
Radio-sensitization was designed with 1.0 mM PA and 0.5 mM POH. Dye-exclusion 
and colony formation assay were employed to test the effects o f either monoterpenes 
alone or irradiation or combination o f both on these cell lines. Pretreatment with 1.0 mM 
PA reduced the number o f viable cells by 10% in H TB -43,19% in SCC-25 and 9% in 
BroTo cells respectively. Exposure o f these cell lines to 2Gy dose o f irradiation alone 
minimally reduced the viability of these cells (Fig. 7, p. 40). When the cells were 
pretreated with 1.0 mM PA or 0.5 mM POH and exposed to IGy dose of radiation the 
viability o f each cell line was reduced as follows; HTB-43 (50% and 71%), SCC-25
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(55% and 68%) and BroTo (18% and 53%) respectively (Fig. 7, p. 40). Similar results 
were obtained when the cells were pretreated with POH or PA and then exposed to 2Gy 
dose of irradiation (Fig. 7, p.40).
The long-term survival o f cells from 12 to 14 days, when pretreated with 
monoterpenes followed by irradiation was also investigated. Figure 8 (p.41) shows the 
quantitative effect o f the respective treatments on the cell lines. Fewer colonies were 
formed in groups pretreated with monoterpenes and exposed to irradiation compared to 
either the control (no treatment, radiation alone or chemotherapy alone) (Fig. 8, p.41). 
SCC-25 cells formed the fewest colonies of all the cell lines (Fig.8, p.41). Quantitative 
examination o f the results (Fig. 9, p.42) showed that pretreatment with monoterpenes 
followed by exposure to irradiation further inhibited proliferation of the HNSCC cells. 
The respective inhibition o f proliferation in HTB-43, SCC-25, and BroTo cells were PA 
(35, 45, 30%) and for POH (60, 55, and 40%) respectively when exposed to IGy of 
irradiation (Fig.9, p.42).
To determine the effects o f the treatment on the cell cycle progression, we performed 
cell cycle analysis on treated cells using a FACSCalibur flow cytometry (Becton 
Dickson, San Jose, CA) following propidium iodide staining. At 24 hr, POH treatment 
induced a block in the G q/G i phase in all the three cell lines at 24 hr while PA treatment 
blocked only BroTo cells in G q/G i but no such effect on the other cell lines (Table 1, 
p.43). At 72 hr, PA induced some G q/G i arrest in all cell lines (Table 1, p.43). Figure 10 
(p.44) shows a plot of the apoptotic index versus different treatments. Apoptotic index 
(AI) was calculated as a ratio o f the mean apoptosis values in the treated groups divided 
by the mean apoptosis values o f respective control for each cell line. Calculation of the
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AI normalized the treatment effect for each cell line, thereby facilitating a comparison 
between them. AI was highest for SCC-25 cells treated with POH and exposed to 2Gy 
dose of irradiation (Fig. 10, p.44). The overall sensitivity of the cell lines were for POH: 
SCC-25>BroTo>HTB-43 and for PA: HTB-43>SCC-25>BroTo respectively (Fig. 10, 
p.44).
To confirm PA or POH induced cell death, both Annexin V (AV) and propidium 
iodide (PI) staining by flow cytometry was performed with HTB-43, SCC-25 and BroTo 
cells exposed to l.OmM PA and 0.5 mM POH for 72 hr exposure. Jurkat T-Lymphocytes 
cells were used as control cell line. The lower left quadrant o f the cytograms shows the 
viable cells, which exclude PI and are negative for FITC-Annexin V binding. The upper 
right quadrant represents the non-viable, necrotic cells, positive for FITC-Annexin V 
binding and showing PI uptake. The lower right quadrant represents the apoptotic cells, 
FITC-Annexin V positive and PI negative, demonstrating Annexin V binding and 
cytoplasmic membrane integrity. The percentage of cells single positive for FITC- 
annexin V binding after treatment with 1.0 mM PA or 0.5 mM POH was 5.9 and 17.9% 
for Jurkat cells (F ig .ll, p. 45), 38.8 and 49.8% for HTB-43 (Fig. 12, p.46.), SCC-25 
having 13.8 and 23.8% (Fig.l3, p.47) and for BroTo cells 1.5% and 0.6% (Fig. 14, p.48). 
We observed high percentage o f late apoptotic cells, double positive for both FITC- 
annexin V/Pl in BroTo cells compare to early apoptotic cells (Fig. 14, p.48).
To discriminate apoptotic cells from necrotic cells, we further visualized apoptotic 
cells using detection system fi’om Phoenix Flow System Inc. The percentage o f live and 
apoptotic cells were quantified using the MultiCycle software. Our data showed that in 
the control cell line (Jurkat cells) only 0.6% and 0.7% of cells were apoptotic compared
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to live cells (Fig. 15, p.49) while for HTB-43 the percentage of apoptotic cells for PA and 
POH treatment was 77.2 and 63.5% respectively (Fig. 16, p.50). In SCC-25 cells 
treatment with 1.0 mM PA and 0.5 mM POH for 72 hr resulted in 62.3 and 78.0% of 
apoptotic cells (Fig. 17, p.51).
4.2 Initial attempt to quantify p53 
When the DNA of a cell is damage due to either radiation or agent, the tumor 
suppressor protein, p53 is activated for repair process. The p53 gene is the most 
commonly mutated gene in human cancers especially in head and neck cancers. In 1996, 
Kiuru et al. and colleagues affirm that since p53 is highly mutated in HNSCC, this will 
probably account for their sensitivity or resistance to either radiation or agent. In an 
attempt to detect or quantify the level of p53 in HNSCC cells, HTB-43, BroTo, and SCC- 
25 cells were treated with PA or POH alone or radiation alone or combination o f both.
We identified and quantified the p53 protein level in HNSCC cells using the BioSource 
p53 (Total) immunoassay called Enzyme Linked-lmmuno-Sorbent Assay (ELISA) by 
referring to a standard curve (plotted in Fig. 18, p.53). With HTB-43 and BroTo cells 
override was observed, meaning that the fluorescence signal exceeded the range for 
detection by the instrument. This was probably due to high level of p53 proteins 
expressed in these two cell lines compared to SCC-25 cells. With SCC-25, the result 
indicated that the level of p53 in the control was higher than the treated group (Table 2 
and Fig. 18, p.52 and p.53). However, these results may not be reliable. Observed protein 
levels should be proportional to the number of cells. We expect the protein in the control 
group to be higher than in the treatment groups because cell number should be greater in
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the control than treated groups due to cell death caused by the agent (for example, see 
Figure 7, p.40). But we observed that the protein level in the treatment groups was 
higher than the control, suggesting that some type o f error may have occurred during this 
experiment. Furthermore, it could be that SCC-25 cells express very little or no p53.
Min et al. (1994) reported that the squamous cell carcinomas of the tongue, SCC-25 have 
p53 levels that are not easily detected. They also reported a p53 mutation observed in 
SCC-25 due to deletion at codon 209 of two base pairs (Min et al., 1994). There is need 
for further investigation o f the p53 protein using western blotting technique, and 
repeating the ELISA. In addition to SCC-25, it may be desirable to look again at more 
diluted samples from HTB-43 and BroTo cells, which appear to have high concentrations 
of p53.
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Figure 5. Inhibition effects o f monoterpenes on human head and neck cancer cells. Cells 
were plated in tissue culture plates and exposed to equimolar concentrations o f PA or 
POH for 24, 48 and 72 hr. AlamarBlue assay was used as described in the text to 
measure the cytotoxicity o f each agent. Values represent Mean ± SD (n=4).
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Figure 6. The response of head and neck squamous cell carcinoma cells to radiation 
exposure. HTB-43, SCC-25 and BroTo cells were plated separately in tissue culture plate 
and exposed to different doses o f irradiation from 1 to 8Gy and allowed to stay overnight. 
Treatment medium and cells were incubated for 5 days. At termination, the effect of 
radiation exposure was determined by alamarBlue assay as described in the text. Graph 
represent Mean ± SD (n=4).
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Figure 7. Monoterpenes sensitized FINSCC cell lines to radiation treatment in vitro. Cell 
lines were treated with 1.0 mM PA or 0.5 mM POH for 72 hr then exposed to IGy or 
2Gy o f X-ray dose. Control cells with or without monoterpenes received no irradiation. 
Cells were harvested, stained with trypan blue dye and proportion o f viable cells relative 
to the control was determined. The graph represent Mean ± SD (n=3) o f % viability 
versus treatment regimen.
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Figure 8. Colony formation in HNSCC cells after combination treatment with 
monoterpenes and radiation. HNSCC cells (SCC-25, BroTo, HTB-43) were exposed to 
0.5mM perillyl alcohol (POH) or l.OmM perillic acid (PA) for 72 hr and then exposed to 
0, 1, or 2Gy X-ray. Cells were harvested, washed with PBS, and cultured in 6-well plates 
(500/well) with complete medium for 14 days. Cells were stained with crystal violet and 
colonies, containing at least 50 cells, were counted. Cell viability was calculated as 
percentage o f the colonies in treated group relative to that of the control groups.
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Figure 9. Monoterpenes delayed proliferation of HNSCC cells in combination treatment 
with irradiation. The cells were treated as described in the legends for Fig.8 (P.41).
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24 hr 72 hr
Cell line Treatment Go/Gi S G2/M Go/G, S G2/M
HTB-43 Control 77.7 9.7 12.6 43.5 44.0 12.5
±0.5 ± 1.8 ±2.3 ± 1.0 ± 1.2 ±0.7
0.5 mM POH 81.5 0.2 18.6 49.5 36.9 13.6
± 1.8 ± 0.1 ± 1.3 ±0 .9 ± 1.2 ±0.5
1.0 mM PA 74.9 14.7 10.4 49.4 36.2 13.6
± 1.3 ± 0.8 ± 2.0 ± 0.8 ± 0.6 ±0.5
SCC-25 Control 46.4 37.2 16.4 43.3 37.6 19.2
± 2.6 ± 1.4 ± 1.4 ±2.7 ± 0 .7 ±3.5
0.5 mM POH 60.9 36.7 2.4 52.5 39.1 8.5
±2.5 ±5 .2 ± 2 .7 ± 1.62 ± 1.1 ±2.3
l.O m M PA 46.7 41.0 12.3 62.9 36.9 14.6
±0.5 ± 1.7 ± 2.2 ±1.7 ±0 .7 ± 1.4
BroTo Control 58.1 26.2 15.8 60.9 30.2 8.8
± 1.0 ±4 .4 ±5 .4 ±0.3 ±0 .4 ± 0.1
0.5 mM POH 72.4 17.8 9.7 57.4 33.1 9.5
± 2.9 ± 2.9 ±2.5 ±0.7 ±0.5 ±0.3
1.0 mM PA 72.4 21.1 6.5 68.0 22.2 9.8
±5.15 ± 5 .4 ±0.3 ±0.25 ± 0.2 ±0.3
Tables 1. Cell cycle distribution o f HNSCC cells treated with monoterpenes. HNSCC 
Cells were harvested after exposure to perillic acid (PA) or perillyl alcohol (POH) for 24 
or 72 hr. The cells were fixed in ethanol and stained with propidium iodide. DNA 
content data were acquired using BD FACSCalibur and CellQuest acquisition software 
(Beckon Dickinson, San Jose, CA). The data were analyzed using ModFit LT version,
3.0 analysis software (Verity software House, Topsham, ME). Values are Mean ± SD 
(n=3).The table is representative of two separate experiments.
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Figure 10. Monoterpenes induced apoptosis in HNSCC cell lines. Human head and neck 
cancer cell lines were treated with 1.0 mM perillic acid (PA) and 0.5 mM perillyl alcohol 
(POH) for 72 hr. At termination, cells were harvested and washed with PBS. Cells were 
fixed in ethanol, washed and stained with propidium iodide and percentage o f cells in 
sub- Go/Gi phase of the cell cycle was quantified using flow cytometry. Figure represent 
apoptotic index (AI) calculated as a ratio o f the mean apoptosis values in the treated 
groups divided by the mean apoptosis of respective control for each cell lines. Values 
represent two separate experiement
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Figure 11. Contour diagram of FITC-Annexin V /PI flow cytometry o f Jurkat cells. 
Control and treated cells were exposed for 72 hr, harvested and washed with 5 ml wash 
buffer. Treated cells with FITC-Annexin V conjugate and stained with PI. Acquisition 
was done with FACSCalibur flow cytometry. Lower left quadrants o f each point show 
the viable cells, which exclude PI and negative for FITC-Annexin V binding. The upper 
right quadrants (DP) contain non-viable cells positive for FITC-Annexin V binding and 
PI uptake. The lower right quadrants (SP) represent the apoptotic cells, single positive 
for FITC-Annexin V and negative PI.
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Figure 12. HTB-43 cells contour diagram of FITC-Annexin V/PI flow cytometry treated 
for 72 hr. Control and treated cells were harvested and washed with 5 ml wash buffer. 
Treated cells with FITC-Annexin V conjugate and stained with PI. Acquisition was done 
by flow cytometry. Lower left quadrants o f each point show the viable cells, which 
exclude PI and negative for FITC-Annexin V binding. The upper right quadrants (DP) 
contain non-viable cells positive for FITC-Annexin V binding and PI uptake. The lower 
right quadrants (SP) represent the apoptotic cells, single positive for FITC-Annexin V 
and negative PL
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Figure 13. Contour diagram of FITC-Annexin -V/Pl flow cytometry o f SCC-25 cells 
exposed for 72 hr. Control and treated cells were harvested and washed with 5 ml wash 
buffer. Cells treated with FITC-Annexin-V conjugate and stained with PI. Acquisition 
was done using flow cytometry. Lower left quadrants of each point show the viable cells, 
which exclude PI and negative for FITC-Annexin V binding. The upper right quadrants 
(DP) contain non-viable cells positive for FITC-Annexin V binding and PI uptake. The 
lower right quadrants (SP) represent the apoptotic cells, single positive for FITC-Annexin 
V and negative PI.
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Figure 14. BroTo cells Contour diagram of FITC-Annexin V/PI flow cytometry of treated 
for 72 hr. Untreated and treated cells were harvested and washed with 5 ml wash buffer. 
Cells were treated with FITC-Annexin -V  conjugate and stained with PI. Acquisition 
was done by flow cytometry. Lower left quadrants o f each point show the viable cells, 
which exclude PI and negative for FITC-Annexin V binding. The upper right quadrants 
(DP) contain non-viable cells positive for FITC-Annexin V binding and PI uptake. The 
lower right quadrants (SP) represent the apoptotic cells, single positive for FITC-Annexin 
V and negative PI.
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FigurelS. Jurkat cell death analysis using BrdUTP labelling. Control and treated groups 
were exposed for 72 hr, then harvested and washed with 5 ml o f wash buffer. Incubated 
cells in DNA labelling for 1 hr at 37°C in water bath. After incubation, cells were rinsed 
twiee with 1.0 ml rinsed buffer and resuspended cell pellet in 0.1 ml o f Fluorescein-PRB- 
1 Antibody solution for 30 minutes in the dark. Add 0.5 ml o f propidium iodide/RNase 
A solution and incubated for more 30 minutes and eells distribution analyzed was 
conducted using flow cytometry. M l and M2 represents live and apoptotic cells.
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Figure 16. HTB-43 cell death analysis exposed for 72 hr using BrdUTP labelling. 
Untreated and treated group were harvested after treatment and washed with 5 ml o f wash 
buffer. Incubated cells in DNA labelling for 1 hr at 37°C in water bath. After incubation, 
cells were rinsed twiee with 1.0 ml rinsed buffer and resuspended in 0.1 ml of 
Fluorescein-PRB-1 Antibody solution for 30 minutes in the dark. Added 0.5 ml of 
propidium iodide/RNase A solution and incubated for another 30 minutes. Cells were 
analyzed using flow eytometry. M l and M2 represents live and apoptotie cells.
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Figure 17. Cell death analysis o f SCC-25 cells exposed for 72 hr using BrdUTP labelling. 
Control and treated cells were harvested after treatment with agent and washed with 5 ml 
of wash buffer. Cells were incubated in DNA labelling for 1 hr at 37oC in water bath. 
After incubation, cells were rinsed twice with 1.0 ml rinsed buffer and resuspended in 0.1 
ml of Fluorescein-PRB-1 Antibody solution for 30 minutes in the dark. Added 0.5 ml of 
propidium iodide/RNase A solution and incubated for another 30 minutes. Cells were 
analyzed using flow cytometry. M l and M2 represents live and apoptotic cells
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Treatment p53
pg/5pl
Protein
ug/5pl
Pg/pg
protein
% o f p53 
level
% reduction 
of p53 level
Control 373.1 &83 54.63 100 0
0.5 mM POH 191.63 9.83 19.5 35.7 64.3
l.O m M PA 69.34 12.49 5.55 10.2 89.8
IGy 59.58 845 6.66 12.2 8T8
2Gy 53.64 15.06 3.56 6.5 93J
IGy/PA 54.55 21.36 2.55 4.1 95.9
2Gy/PA 78.15 14.53 5.38 9.8 90.2
Table 2. Reduction o f p53 protein level in SCC-25 cells in culture. Cell samples and 
standards were added to microtiter wells coated with p53 antibody and incubated for 2 
hours. Aspirated solution in wells washed 4 x with wash buffer and pipetted 100 pi anti- 
p53 detection antibody in to wells except chromagen blanks. Covered plate and 
incubated for 1 hour. Aspirated off solution, washed wells 4x with wash buffer and 
added 100 pi anti-rabbit IgG-HRP working solution and incubated for 30 minutes. 
Washed and added standard chromagen to all wells, incubated for 30 minutes in the dark 
at room temperature. Added stop solution to each well and read the absorbance at 450 
nm. Table represents average o f duplicate reading for p53 protein level.
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Figure 18. The expression o f p53 protein in SCC-25 cells following chemo-radiation 
treatment with monoterpenes: Added lOOpl (5pi sample into 95pi) of sample in 
appropriate microtiter wells and incubated for 2 hrs. Pipitted lOOpl of anti-p53 into each 
well after washing with buffer. Covered and incubated plate for 1 hr. Washes 4x with 
buffer and adds lOOpl o f anti-rabbit IgG-HRP working solution except blank well and 
incubates for 30 minutes. Wash 4x with buffer and added lOOpl o f standard chromagen 
and incubated in dark for 30 minute. Add lOOpl o f stop solution and Read absorbance at 
450 nm. Figure represents values of the treated groups compared with standard values.
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CHAPTER 5
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS.
5.1 Discussions o f results 
During cell growth, the metabolic activity results in a chemical reduction of the 
alamarBlue dye from blue to red indicating cell viability. Continued cell proliferation 
maintains a reduced environment (change o f dye color to red) while inhibition of growth 
maintains an oxidized environment (no change in dye color, blue). Reduction related to 
cell growth causes the alamarBlue dye to change from oxidized form to reduced form. 
Fluorescence intensity is proportional to the number of viable cells and comparison of 
this intensity in treated cells to that o f the untreated control is used as a measure of 
cytotoxicity o f PA or POH on cell growth. In this present study, treatment o f HNSCC 
cells to either 1.0 mM PA or 0.5 mM POH inhibited the proliferations o f cells in a time- 
dependent manner with drastic effect observed after 72 hr exposure in all the cell lines 
(Fig.5, p.39).
We have tested a low dose (0.5 mM) of POH and physiological achievable level 
(1.0 mM) of PA as agents for use in combination chemo-radiation treatments. POH or 
PA alone minimally affected the viability (Fig.7 and 9, p.41 and 43) or proliferation 
(Fig.9, p.43) of HNSCC cells in culture. However, when the cells were pretreated with 
each monoterpenes and then exposed to IGy dose o f irradiation, the combination 
treatment with PA significantly (p<0.01) reduced the survival o f HTB-43 and SCC-25
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cells (Fig. 7 and 9, p.40 and 42) as well as that o f BroTo cells (p<0.01). The reduction in 
viability was as a result of apoptosis induction as shown in Figure 10 (p.45). Induetion of 
apoptosis was assessed as apoptotic index (AI) derived as a ratio of mean apoptosis 
values of treated cells to that o f the control cells. POH, in combination with irradiation, 
induced higher apoptosis than PA (Fig. 10, p.45) although the sensitivity o f the cell lines 
appears to take similar trends: SCC-25>HTB-43>BroTo. BroTo cells appeared less 
affected by monoterpenes and/or irradiation compared to SCC-25 and HTB-43 cells (Fig. 
10, p.45)
In the studies investigating the long-term effects, we found that pretreatment with 
monoterpenes followed by irradiation inhibited the proliferation o f the cancer cells (Figs.
8 and 9, p.42 and 43). Our data eonfirm the radio-sensitization effects of the 
monoterpenes. These results are in agreement with reeent reports by Rajesh et al (2003) 
showing that pretreatment of glioma eells with POH sensitized the cells to irradiation. 
These authors further coneluded that the mechanism of action included enhanced 
apoptosis induetion in the treated cells, although they used higher irradiation doses (5Gy) 
eompared to the dose used in the present study.
To eonfirm apoptosis induction by the monoterpenes, FITC-Annexin -V/PI 
staining flow eytometry was performed with head and neek caneer cells, Jurkat cells 
serving as the eontrol eells. In the early stages of apoptosis one of the ehanges that occur 
at the cell surface involves the translocation o f phosphatidylserine (PS) from the inner 
side of the plasma membrane to the external surfaee o f the cell. Annexin-Y being a Ca 
dependent phospholipids binding protein binds to PS with high affinity at the external 
surface, hence it is used to measured cells that undergo early apoptosis. We report that
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pretreatment with 1.0 mM PA or 0.5 mM POH increased the cell population of both 
necrotic and apoptotic cells (p.46-49) confirming the observation seen with increased in 
apoptotic index in HNSCC cells . For cells that are apoptotic, the plasma membrane 
remains intact, but necrotic cells release its content leading to shrinking o f plasma 
membrane. Figures 11-17 (p.46-49) shows the results o f applying annexin V assay to 
indicate the number o f apoptotic and necrotic cells in relation to time elapsed after 72 hrs 
treatment with PA or POH (p.46-49). We confirm that pretreatment o f cells prior to 
radiation by monoterpenes results into induction of apoptosis (Fig. 17 and 18, p.52-53).
5.2 Conclusions and recommendations for further study
In a biological system, when radiation is absorbed, free radicals are produced that 
cause the breakage o f the nucleic acids and other macromolecules, causing DNA damage. 
Many drugs have been reported to have the properties o f inhibiting the repair o f the DNA 
damage in cancer cell caused by radiation exposure (Rosenthal et al., 1998). Our data 
indicated that the monoterpenes acted as radiosensitizers through the induction of cell 
death via apoptosis in combination chemo-radiation treatment o f head and neck cancer 
cells in vitro. Our data also indicated that the monoterpenes POH as well as its 
metabolite PA acted as radiosensitizers in combination chemo-radiation treatment o f head 
and neck squamous cell carcinoma in vitro.
As the knowledge of the molecular events surrounding the cause o f cancer has 
advanced, attention has been center on developing novel agents with new mechanisms of 
action. Since this was the first research work to elucidate the radio-sensitization of
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perillic acid in head and neck cancer cells, further studies on the sensitization effect o f the 
monoterpenes will help in elucidating the mechanism of action. This will include
(i) the effects o f higher radiation doses
(ii) the effects o f fractionated doses
(iii) comparative effects o f alternating and concomitant chemo-radiation 
protocols
(iv) the role o f monoterpenes in the expression levels of p53 and other related 
signaling proteins like bcl-2, p21 in downstream of p53 regulation
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5.3 Definition of terms
Terms Definition
Apoptosis Programmed cell death
Necrosis Death of cells through injury, disease or treatment.
HNSCC Head and neek squamous cell carcinoma
Cell cycle arrest The halt in a series o f events involving the growth, 
replication, and division of a eukaryotic cell
p53 Tumor suppressor protein
Squamous cell carcinoma Cancerous cells that affect the middle layer o f the skin
Inhibition The reduction or of a biochemical reaction, due to 
interaction with a chemical agent
Proliferation Continuous development of cells
Gy Gray is the imit of radiation dose
Go-Phase Resting period of cells
Gi-Phase Growth and preparation of the chromosomes for 
replication
G2-Phase Preparation for cell division
M-Phase Mitosis or cell division
S-Phase Synthesis of DNA
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SUMMARY:
Several of the current chemotherapeutic drugs (vinblastine, methotrexate, taxol, 
etc) were first identified in plants. In developing countries, the practice o f medicine still 
relies heavily on plant and herbal extraets for the treatment of human ailments. Current 
interests in phytochemicals as agents for the treatment of human cancers were rekindled 
because these compounds occur naturally and are less toxic than synthetic agents. 
Monoterpenes occur naturally in a wide variety of plants while the jasmonates are a 
family of plant stress hormones. We studied the effects o f the naturally occurring 
monoterpene, perillyl alcohol (POH) and its major human metabolite, perillic acid (PA), 
on human head & neck (BroTo and SCC-25), and human lung carcinoma (HTB-182 and 
CRL-5928) cell lines. We also studied the effects o f the jasmonates on human prostate 
adenocarcinoma (PC-3 and HTB-81) cell lines in culture. Both classes o f compounds 
inhibited the proliferation o f cancer cells. POH was more effective than PA at reducing 
the proliferation o f human head & neck and lung squamous cell careinoma cells. The 
jasmonates also inhibited the proliferation o f prostate cancer cells. Differential potencies 
were observed between the various members o f the jasmonate family. The monoterpenes 
and the jasmonates should be further investigated for their effeets on human cancer cell 
lines.
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INTRODUCTION:
The effects o f several plant compounds on animal cells have been studied. Plant 
compounds such as carotenoids, lycopene, indoles, thiocyanates and others exhibit 
antioxidant properties in animal cells while the carotenoids and vitamin E also serve as 
nutrients. Other plant compounds such as tea polyphenols, indoles and monoterpenes 
showed chemopreventive activity in a number of human cancers (1-3).
Monoterpenes are a diverse class o f isoprenoid compoimds synthesized by plants 
through the mevalonate pathway (4). d-Limonene (LIM) and perillyl alcohol (POH) are 
naturally occurring monoterpenes commonly found in the essential oils of citrus fruits, 
lavender, spearmint, cherries and others (5,6). Both LIM (7-9) and POH (10) elicited 
chemotherapeutic effects against mammary tumors causing the complete regression of 
more than 80% of established DMBA- or NMU-induced mammary carcinomas. In vivo. 
both POH and LIM are readily metabolized to the major metabolites, perillic acid (PA) 
and dihydroperillic acid (DHPA), in experimental animals (11). Pre-clinical and 
pharmacokinetic studies of limonene (12,13) and POH in humans (14,15) showed that 
human metabolites o f both agents (16) are similar to the metabolic profile observed in 
experimental animals (11). Although the mechanism of the anti-tumor action of the 
monoterpenes is not yet known, several potentially important drug-related activities have 
been observed (17-21).
The jasmonates, first isolated from the jasmine plant, are a class o f plant stress 
hormones consisting of cis-jasmone (CJ), jasmonic acid (JA), and methyl jasmonate (MJ) 
respectively (22). JA is involved in the intracellular signaling response by plants to injury 
while MJ causes the induction o f a proteinase inhibitor, which accumulates in response to
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wounding or pathogenic attacks (23). In plants, this response is termed the 
hypersensitive response (HR) and results in the formation of a zone o f dead cells around 
the infection site, the synthesis o f salicylic acid and the accumulation o f antimicrobial 
agents, such as pathogenesis-related proteins and phytoalexins (24,25). The layers of 
dead cells that surround the site of pathogen entry are thought to function as a physical 
barrier that inhibits further proliferation and spread of the pathogen.
Available reports indicate that the jasmonates may also have effects on animal 
cells in culture. Jasmone and analogs, for example, inhibited the proliferation and 
induced cell death in lymphoblastic leukemia (MOLT-4) and breast cancer cells cultured 
in vitro, but did not affect normal human blood lymphocytes or erythrocytes (26). JA and 
MJ caused apoptotic death, increased caspase-3 activity and induced mitochondrial 
membrane depolarization in these cell lines (26).
We postulated that these plant compounds might inhibit the proliferation of 
human cancer cells in vitro. We, therefore, investigated the effects o f the monoterpenes 
(POH and PA) on the proliferation o f human squamous cell carcinoma of the head & 
neck (BroTo; SCC-25) and lung (HTB-182; CRL-5928) cell lines. We also studied the 
effects o f the jasmonates on prostate adenocarcinoma (PC-3; HTB-81) cell lines cultured 
in vitro. The effects of these agents on human lung fibroblast, normal (HFL-1), cultured 
in vitro were also evaluated. In this report, we present preliminary findings showing that 
these bioactive plant compounds inhibited the proliferation and induced cell death in 
human cancer cells in culture.
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MATERIALS AND METHODS:
Chemicals and Reagents:
The monoterpenes (POH and PA) were obtained from Aldrich Chemical 
Company (Milwaukee, WI). The jasmonates (CJ, JA, MJ) were purchased from Sigma 
Chemical Company (St. Louis, MO). Cell culture media (RPMI, EMEM, DMEM,
Ham’s F12 and Ham’s F12-K) were obtained from ATCC (Manassas, VA). Phosphate 
buffered saline (PBS, lacking Ca^^ and Mg^^), penicillin (100 units/ml) and streptomycin 
(lOOpg/ml) (P/S) were obtained from Invitrogen Corporation (Grand Island, NY). Fetal 
bovine serum (FBS) was purchased from HyClone Laboratories (Logan, UT). All other 
reagents and chemicals were o f the purest grade and procured from reputable vendors.
Cells and Cell Culture:
Human squamous cell carcinoma o f the tongue (SCC-25), human squamous cell 
carcinoma of the lung (HTB-182 and CRL-5928), human prostate adenocarcinoma (PC-3 
and HTB-81) and human lung fibroblast, normal, (HFL-1) cell lines were purchased from 
ATCC (Manassas, VA). Human squamous cell carcinoma of the tongue (BroTo) cell line 
was a gift from J. Truelson, MD, Department of Otolaryngology, University of Texas- 
Southwestern Medical Center. Cells were cultured in appropriate media supplemented 
with 10% FBS and 1% P/S. Cells were dislodged with trypsin-EDTA, adequate amounts, 
as specified in each study, were plated and allowed to adhere onto tissue culture plates 
overnight. The respective monoterpene (POH, PA) or jasmonates (JA, CJ, MJ) was 
dissolved in DMSO to give a I .CM stock solution. Cisplatin was mixed directly with 
sufficient medium to achieve the desired concentration. Treatment solutions were
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prepared by diluting the stoek solution with the appropriate medium, with occasional 
mixing at 37°C for at least 1 hr, before use. Cells were treated by replacing the growth 
medium with medium containing the desired concentration of each agent and incubated at 
37°C in humidified, 5% CO2 atmosphere. Cells in control wells received either medium 
only (for cisplatin and 5-FU controls) or medium containing DMSO (<0.3% v/v; for 
jasmonate and monoterpene controls). At stated time points, effects o f the agents were 
determined as described below.
Cvtotoxicitv Assavs:
Mitochondrial Dehvdrogenase TMTT) Assav:
The effects of the different agents on cancer cell lines were studied using the 
MTT assay (27), an assay based on the reduction of the yellow dye, 3-(4,5-dimethyl-2- 
thiazol)-2,5-diphenyl-2H-tetrazolium bromide (MTT) to purple formazan crystals by the 
mitochondrial dehydrogenase enzyme. Specifically, cells (5,000 cells/well) were plated 
in 96-well plates and allowed to adhere overnight. Cells were treated with the agents or 
the appropriate Control medium for up to 72 hr. After exposure to the agent for a 
specified period of time, the treatment medium was replaced with lOOpl of fresh medium 
and lOpl of MTT (5mg/ml) and the plate incubated at 37°C in humidified 5% CO2 
atmosphere for 3 hr The reaction was stopped and the formazan crystals solubilized with 
lOOpl of the stop solution (O.IN HCl in isopropanol). The optical density of the solution 
was read at 570nm against a reference at 630nm on an ELISA plate reader (Packard 
Instruments, Meridan, CT). Cell viability was calculated as a percentage o f the control 
cells (100%).
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Colony Formation Assav:
The long-term effects o f the agents on the treated cells in culture were assessed 
using the colony formation assay (CFA) as previously described (28). Specifically, cells 
(200-500 cells/well) were plated in 6-well plates and allowed to adhere overnight. The 
following day, the control or the treatment medium (with the desired concentration of an 
agent) was added to appropriate wells and incubated for the desired time period. Cells 
were washed twice with IX  PBS and once with the fresh medium. Fresh medium was 
then added to each well and the cells were incubated for 10-14 days. The plates were 
viewed under the microscope every other day to monitor cell growth. At termination, the 
medium from each well was removed by aspiration, the cells washed with IX PBS and 
the colonies stained with crystal violet (0.5% in 95% ethanol) for 5 min and the dye was 
gently rinsed off. Colonies, each containing at least 50 cells, were counted and the cell 
viability or drug effectiveness was assessed based on the number o f colonies formed in 
the treatment group relative to the control (100%).
Flow cytometry analysis for cell cycle distribution:
The DNA content o f treated cells was assessed by flow cytometry following 
propidium iodide (PI) staining as previously described (28). Cancer cells (5 x 10^) were 
plated in a 60mm diameter tissue culture plate overnight to adhere. The cells were then 
treated with varying concentrations o f POH, PA or MJ for the specified period of time. 
Following treatment, cells were harvested, washed, re-suspended in lOOp.1 o f ice-cold 
PBS, fixed with 90% ethanol and kept at 4°C prior to flow analysis. To determine the
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cell cycle distribution and to quantitate apoptotic cells with subdiploid DNA content, 
cells were stained with DNA staining solution (100 pg/ml PI, 0.1% Triton X-100, and 1 
mg/ml RNase A (DNase-free) in PBS lacking Ca^^, Mg^^; 1:1:1 by volume) and analyzed 
using a FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA). PI fluorescence 
was linearly amplified and both the area and width o f the fluorescence pulse were 
measured. Twenty thousand events were acquired and the percentages of hypodiploid 
(apoptotic; sub-Go/Gi) events and of cells in Go/Gi, S and Gi-M phases were determined 
using the DNA analysis software ModfitLT version 3.0 (Verity Software, Topsham, 
Maine).
Statistical Analvses:
Results were expressed as Mean ± SD of replicate analyses accompanied by the 
number of independent experiments. Data analyses were performed by one-tailed t-test. 
Differences at p<0.05 or better were considered statistically significant.
RESULTS:
Effects o f monotemenes on squamous cell carcinomas:
The effects of the monoterpenes (POH and PA) on the proliferation of human 
head & neck squamous cell carcinoma and human lung fibroblast (HFL-1) cells in culture 
were evaluated using MTT and CFA techniques. The concentration of POH that 
inhibited proliferation by 50% ( I C 5 0 )  was calculated (Fig 1) to be 625pM (BroTo),
SOOpM (HFL-1) and 930pM (SCC-25). BroTo cells appeared more sensitive to POH 
than SCC-25 and HFL-1 cells. PA was not as effective as POH against the cell lines
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though at concentrations greater than 750pM, PA inhibited proliferation o f SCC-25 cells 
by greater than 30% (Fig IB). POH (Fig 1 A) was more effective than PA (Fig IB) at 
reducing cellular proliferation. We evaluated the long-term effects of cell exposure to the 
monoterpenes using colony formation assay technique. Exposure to POH (500pM or 
lOOOpM) for 24 hr significantly (p < 0.05) reduced the proliferation of SCC-25 and 
BroTo cells. HFL-1 cells also appeared very sensitive to POH. Figure 2B shows the 
effect o f PA on these cell lines. Similar to earlier observations (Fig IB), SCC-25 cells 
appeared more sensitive to PA than either the BroTo or HFL-1 cells. Exposure to 
lOOOpM PA inhibited the proliferation of SCC-25 cells by >25% (Fig 2B).
We also examined the effects o f the monoterpenes on human lung squamous cell 
carcinoma cell lines (CRL-5928 and HTB-182). Both POH and PA reduced the 
proliferation of CRL-5928 cells in dose- and kinetic-dependent manners (Fig 3). The 72- 
hr IC50 for POH was 750|xM compared to 1800 pM for PA (Fig 3). Similar responses 
were observed with HTB-182 (data not shown). We also compared the effects o f POH 
(500pM), PA (lOOOpM), cisplatin (2.5pg/ml) and 5-FU (lOOpg/ml) on the human 
squamous cell carcinoma (HTB-182) cell line treated for 24,48 or 72 hr using 
mitochondrial dehydrogenase assay technique (Fig 4). We found that at 48 hr, the 
monoterpenes reduced cellular proliferation better than in the groups treated with 
cisplatin or 5-FU (Fig 4). The relative efficacy of these agents, at the stated 
concentrations and 48 hr exposure, were POH>PA>cisplatin>5-FU (Fig 4). The response 
to POH at 72 hr (Fig 4) is not clear.
Effects o f the iasmonates on human prostate cancer cells:
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We also evaluated the effects of the plant stress hormones on human prostate 
adenocarcinoma (PC-3; HTB-81) cell lines cultured in vitro. Figure 5 shows the 
comparative effects o f the jasmonates on human adenocarcinoma cell lines treated for 72 
hr. The IC50 values were MJ (1.8mM) and CJ (2.25mM). An IC50 value was not 
achievable for JA (Fig 5A). PC-3 cells exhibited differential sensitivities to the three 
jasmonates with MJ being more effective than CJ or JA at reducing the proliferation of 
the cancer cells (Fig 5A). At concentrations greater than 2.0mM, MJ significantly 
inhibited proliferation of PC-3 cells better than CJ (p<0.05) or JA (p<0.005). MJ also 
significantly (p< 0.005) inhibited the proliferation o f HTB-81 prostate cancer cells better 
than CJ or JA (Fig 5B) at ImM concentration or higher.
Plant compounds induced cell cvcle arrest and sub-Gn/Gi populations in cancer cells:
In preliminary experiments, we studied the effects of POH, PA and MJ on cell 
cycle distribution and subdiploid DNA content o f cancer cells. POH caused cell cycle 
arrest in the G q/G i phase and an increase in the hypodiploid content o f SCC-25 and 
BroTo cells (Table 1 A) after 24 hr exposure. PA also caused cell cycle arrest in the 
Go/Gi phase in BroTo cells but not in SCC-25 cells and slightly increased the sub-Go/Gi 
content compared to the control (Table lA). Table IB shows that MJ (at 2mM) caused 
cell cycle arrest at G q/G i phase in both PC-3 and HTB-81 cell lines in a time-dependent 
fashion. The cell cycle arrest was accompanied by increased proportion o f sub-Go/Gi 
population in both cell lines (Table IB). These preliminary data will be further studied to 
confirm the induction o f apoptosis.
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DISCUSSION AND CONCLUSION:
We used biochemical, cytotoxicity and flow cytometric assays to evaluate the 
potential effects o f 2 major plant compounds on the proliferation o f several human cancer 
cell lines in culture. We found that POH and, to a lesser extent PA, the major circulating 
metabolite o f the monoterpenes, reduced the proliferation of human head & neck 
squamous cell carcinoma SCC-25 (Fig 1), human lung squamous cell carcinoma cell 
lines CRL-5893 (Fig 3) and HTB-182 (Fig 4) in culture. Our data suggest that the 
mechanism for the proliferation inhibition by these compounds may involve cell cycle 
arrest and the induction o f apoptosis. Ongoing and further investigations will confirm 
these effects.
Several reports have indicated that naturally occurring monotepenes (d-limonene 
and perillyl alcohol) are present in human diets (13,29,30) though only the metabolites of 
these compounds have been detected in blood plasma following consumption o f the 
monoterpenes (12-16). Since the monoterpenes are protective against a number o f 
different cancers (7-10,17,20) and are currently being studied in clinical trials (12,14,15), 
we postulated that the mechanism of action of these compounds would involve the 
circulating metabolites. Furthermore, recent reports indicated that PA, at doses (1- 
3.5mM) higher than physiologically achievable levels, inhibited the proliferation of 
human colon cancer cells by the up-regulation of p21^^^^ '̂^  ̂protein and down- 
expression of cyclin D1 and cdk4 proteins (31). PA also inhibited the proliferation of 
smooth muscle cells via the inhibition o f protein prénylation (32). In cultured rat lens, 
however, PA appeared to induce opacification o f the cultured lenses (33) but via a 
mechanism other than the inhibition of isoprenylation. Our results, showing cell cycle
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arrest and the inhibition of proliferation of these cancer cells at physiologically 
achievable PA concentrations, are in agreement with these reports (30-33).
When we tested the plant stress hormones on human prostate adenocarcinoma cell 
lines, we found that MJ was a more potent inhibitor of the proliferation of the cancer cells 
in culture than CJ or JA. Although CJ showed some activity against PC-3 cell line (Fig 
5 A), it did not elicit any inhibitory effect on HTB-81 cells at the concentrations tested.
JA was the least effective, not showing any effect on either cell line (Fig 5). These 
results are in agreement with the reports by Fingrut and Flescher (26) who tested the 
jasmonates on human leukemia (MOLT-4) and breast cancer cell lines. These 
investigators found that MJ was a more potent inhibitor of proliferation of the cells than 
JA. They concluded that the mechanism of action o f MJ appeared to be via the induction 
of apoptosis (26). Our preliminary flow cytometry data following the propidium iodide 
staining and DNA analysis o f cells treated with POH, PA or methyl jasmonate (Table 1) 
indicated that the inhibition o f proliferation by these plant compounds and metabolite 
might be through cell cycle arrest and the induction o f apoptosis.
The role o f plant compounds on the etiology of human diseases is currently being 
investigated intensively. Evidence show that as humans include more plant products in 
their diets, the potential for the consumption of several plant compounds that may be 
protective against human diseases increases. Current efforts to identify, characterize and 
understand the mechanism of action o f these bioactive plant compounds are in the right 
direction. Further studies are in progress to delineate the mechanism(s) o f action o f the 
monoterpenes and the jasmonates, and to assess their potential effects on human cancer 
cells.
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Table 1; Effects o f bioactive plant compounds on cell cycle distribution and hypodiploidy 
in head & neck squamous cell carcinoma (1 A) and prostate adenocarcinoma (IB) cell 
lines in vitro.
lA: Effect o f 24 hr exposure to POH and PA on BroTo and SCC-25 cell lines
BroTo SCC-25
Treatment G o / G i S G i - M sub-
G o / G i
G o / G , S G 2 - M sub-
G o / G i
Control 54.0 33.2 12.8 0.33 46.1 38.2 15.7 0.28
±7.1 ± 5 .0 ± 2.1 ± 0.1 ±4.5 ± 2 .7 ± 1.8 ± 0.1
0.5mM 76.5 12.0 11.5 2.87 65.7 23.9 10.5 9.55
POH ± 2 .9 ±2.5 ±0 .4 ± 1.1 ±0.5 ± 0 .9 ±0 .3 ± 0.2
l.OmM 70.7 18.5 10.8 1.36 45.4 41.7 12.8 0.54
PA ±3.1 ±4 .7 ± 1.6 ± 0.1 ±0.5 ± 0.8 ±0.5 ± 0.1
IB: Effect of methyl jasmonate (MJ) on PC-3 and HTB-81 cells in culture
PC-3 HTB-81
Treatment G o / G i S G 2 - M sub-
G o / G i
G o / G i S G 2 - M sub-
G o / G ,
Control 51.9 27.0 21.2 0.11 53.8 30.0 16.2 0.33
24 hr ±0.3 ± 0.4 ± 0.7 ± 0.0 ±0.5 ± 0.6 ± 1.1 ±0.3
2.0mM 46.3 30.8 22.9 0.12 40.6 32.9 26.5 1.02
MJ ±0.4 ± 0.1 ±0.3 ± 0.1 ±3.0 ±0.3 ± 2 .7 ± 0 .7
Control 53.8 26.9 19.3 0.15 81.0 9.9 9.1 0.15
48 hr ± 1.5 ± 1.6 ± 0.1 ± 0.0 ± 1.4 ±0.5 ± 0 .9 ± 0.0
2.0mM 73.0 5.5 21.5 1.63 51.8 20.7 27.5 4.0
MJ ± 1.0 ± 1.8 ± 0.8 ± 2.0 ±6.9 ± 0.6 ± 6.2 ± 1.0
Control 70.7 13.2 16.2 0.14 87.8 5.6 6.6 0.18
72 hr ±0.3 ± 0.6 ± 0.8 ± 0.1 ±0.5 ± 0.6 ± 0.1 ± 0.0
2.0mM 48.2 28.2 23.7 0.3 48.1 31.3 20.6 8.8
MJ ±0.3 ± 0.1 ± 0.2 ± 0.2 ± 4.2 ± 6.3 ± 2.1 ± 3 .4
Cancer cells ( 5 x 1 0 )  were plated in 60mm diameter tissue culture plates and treated with 
POH, PA or MJ for the specified period of time and analyzed on a FACSCalibur flow 
cytometer as described in the text. Values are Mean ± SD of triplicate analyses. 
Sub-Go/Gi = % Apoptosis or hypodiploid population
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FIGURE LEGENDS:
Figure 1: Effect o f the monoterpenes on human head and neck cancer (SCC-25; BroTo) 
and human lung fibroblast (HFL-1) cells in culture. Cells were exposed to varying 
concentrations o f perillyl alcohol (POH) or perillic acid (PA) for 24 hr and the effects 
assessed by mitochondrial dehydrogenase assay as described in the Methods section. 
Cytotoxicity was measured as cell viability. Cell viability was calculated as a percentage 
o f untreated Control cells (100%). Figure represents a plot of the log value of % viability 
versus concentration o f monoterpene. Values are Mean ± SD (n=6); result is 
representative of 3 separate experiments.
Figure 2 : Monoterpenes caused long-term inhibition of proliferation o f cells in culture. 
Human cancer (SCC-25; BroTo) or human fibroblast (HFL-1) cells were exposed to 
equimolar concentrations o f perillyl alcohol (POH) or perillic acid (PA) for 24 hr and the 
effects determined by colony formation assay as described in the Methods section. The 
colonies (containing >50 cells/colony) formed were counted and the cell viability was 
calculated as a percentage of the untreated Control groups (100%).
Figure 3: Cytotoxic effects o f monoterpenes on human lung cancer cell line CRL 5928. 
Cells were exposed to varying concentrations of perillyl alcohol (POH) or perillic acid 
(PA) for 24, 48 or 72 hr and the effect evaluated as described for Figure 1.
Figure 4 : Sensitivity o f lung squamous cell carcinoma cells to different chemotherapeutic 
agents. Human lung cancer (HTB-182) cells were exposed to perillyl alcohol (POH),
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perillic acid (PA), cisplatin or 5-fluorouracil (5-FU) for 24,48 or 72 hr and the viability 
determined using the MTT assay technique as described for Figure 1.
Figure 5: Comparative effects of the jasmonates on human prostate cancer cells in 
culture. Human prostate adenocarcinoma cell lines PC-3 or HTB-81 were treated with 
varying concentrations o f jasmonic acid (JA), cis-jasmone (CJ) or methyl jasmonate (MJ) 
for 72 hr and the cytotoxicity determined as described for Figure 1.
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Figure 1 : Effects o f monoterpenes on human head & neck cancer and
fibroblast cells in culture
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Figure 2: Monoterpenes caused long-term inhibition o f  
proliferation o f  cancer cells in culture
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Figure 3: Monoterpenes exhibited cytotoxic effects against human lung cancer
(CRL 5928) cells in culture
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Figure 4: Sensitivity o f  lung squam ous cell carcinom a (H TB- 
182) cells to different chemotherapeutic agents
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Figure 5: Comparative effects o f  the jasmonates (JA, CJ, MJ) on 
cultured human prostate cancer (PC-3; HTB-81) cells
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